MONZA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 8.327
AS - Asia 6.136
EU - Europa 4.133
SA - Sud America 678
AF - Africa 86
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.380
Nazione #
US - Stati Uniti d'America 8.142
VN - Vietnam 1.892
SG - Singapore 1.793
CN - Cina 1.216
IT - Italia 904
DE - Germania 775
RU - Federazione Russa 733
HK - Hong Kong 654
BR - Brasile 569
SE - Svezia 502
IE - Irlanda 317
GB - Regno Unito 238
IN - India 131
CA - Canada 126
FR - Francia 118
UA - Ucraina 108
ID - Indonesia 87
FI - Finlandia 78
TR - Turchia 73
DK - Danimarca 70
KR - Corea 70
AT - Austria 49
AR - Argentina 47
LT - Lituania 47
JP - Giappone 45
NL - Olanda 42
ES - Italia 41
ZA - Sudafrica 41
BD - Bangladesh 39
MX - Messico 38
PL - Polonia 30
BE - Belgio 27
IQ - Iraq 20
EC - Ecuador 18
SA - Arabia Saudita 17
IR - Iran 14
PY - Paraguay 13
CO - Colombia 11
AU - Australia 10
CZ - Repubblica Ceca 10
KZ - Kazakistan 10
PK - Pakistan 10
UZ - Uzbekistan 10
MA - Marocco 9
CH - Svizzera 8
TW - Taiwan 8
VE - Venezuela 8
EG - Egitto 7
TN - Tunisia 7
BG - Bulgaria 6
CR - Costa Rica 6
HR - Croazia 6
RO - Romania 6
UY - Uruguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
EU - Europa 5
IL - Israele 5
KE - Kenya 5
PA - Panama 5
RS - Serbia 5
ET - Etiopia 4
KG - Kirghizistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
AO - Angola 3
BH - Bahrain 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AL - Albania 2
BN - Brunei Darussalam 2
CL - Cile 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
LB - Libano 2
NI - Nicaragua 2
OM - Oman 2
AM - Armenia 1
BB - Barbados 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
TG - Togo 1
TH - Thailandia 1
TL - Timor Orientale 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.380
Città #
Ann Arbor 1.890
Singapore 1.108
Dallas 849
Ashburn 736
Hong Kong 649
Ho Chi Minh City 557
Frankfurt am Main 500
Hanoi 458
Wilmington 368
Milan 362
Chandler 358
Woodbridge 314
Dublin 307
Dearborn 246
New York 242
Fairfield 213
Houston 189
Santa Clara 181
Los Angeles 177
Beijing 166
Princeton 140
Nanjing 116
Jacksonville 106
Hefei 105
Seattle 100
Boardman 91
Shanghai 75
Guangzhou 69
Moscow 68
Jakarta 67
Buffalo 65
Cambridge 65
The Dalles 57
São Paulo 53
Seoul 52
Haiphong 50
Dong Ket 49
Munich 49
Chicago 48
Da Nang 47
Ha Long 41
Biên Hòa 39
Vilnius 39
Nanchang 38
Vienna 35
Nuremberg 34
Bắc Giang 33
Hangzhou 33
Lawrence 33
Ninh Bình 33
Altamura 32
Quận Bình Thạnh 32
Pune 31
Shenyang 31
Montreal 30
Council Bluffs 29
Denver 29
Hải Dương 29
Toronto 29
Can Tho 27
Helsinki 27
Zhengzhou 27
London 26
Orem 26
Tokyo 26
Vũng Tàu 26
Rome 25
Brooklyn 24
Carate Brianza 24
Thái Nguyên 24
Tianjin 24
Warsaw 24
Johannesburg 22
Phoenix 22
Brussels 21
Ottawa 21
Poplar 21
Shangdi 21
Stockholm 21
Atlanta 20
Quận Một 20
Rio de Janeiro 20
Andover 19
Fremont 19
Kunming 19
Turku 19
Kent 18
Phủ Lý 18
Quận Phú Nhuận 18
San Diego 18
Changsha 17
Kocaeli 17
Bắc Ninh 16
Jiaxing 16
Lang Son 16
Quận Sáu 16
Sacramento 16
Chennai 15
Falls Church 15
Jinan 15
Totale 12.818
Nome #
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 507
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 503
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 461
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 455
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 424
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 378
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 370
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 332
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 326
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 321
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 320
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 319
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 314
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 314
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 309
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 308
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 303
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 299
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 291
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 288
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 269
In vitro models for studying oxaliplatin neurotoxic effects 267
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 265
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 263
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 258
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 256
Incubation with low doses of oxaliplatin modifies the electrophysiological properties of dorsal root ganglion neurons 255
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 254
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 249
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 249
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 247
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 246
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 245
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 243
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 238
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 236
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 232
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 230
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 230
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 230
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 228
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 228
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 228
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 226
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 220
Thermal plantar test in experimental ischemic stroke 218
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 217
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 210
Multimodal experimental approach to the study of human neurological diseases 206
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 204
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 201
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 199
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 194
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 191
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 190
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 189
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 188
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 183
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 183
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 178
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 177
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 176
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 172
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 171
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 170
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 170
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 170
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 168
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 167
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 164
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 162
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 162
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 160
Pharmacokinetics of IVIg in Wistar rats 159
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 158
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 144
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 142
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 140
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 135
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 135
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 133
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 132
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 129
A mechanistic understanding of the relationship between skin innervation and chemotherapy-induced neuropathic pain 125
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 124
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 100
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 94
Totale 20.224
Categoria #
all - tutte 62.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.467 0 0 0 0 0 226 249 254 179 160 161 238
2021/20221.207 122 164 133 116 84 96 60 54 49 63 84 182
2022/20231.828 198 362 223 187 155 304 58 84 120 31 64 42
2023/20241.293 56 46 59 76 144 292 191 75 63 32 40 219
2024/20253.884 163 470 343 160 320 141 300 138 422 582 318 527
2025/20266.704 2.150 1.027 1.215 871 992 449 0 0 0 0 0 0
Totale 20.224